Compare NMR & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMR | WST |
|---|---|---|
| Founded | 1925 | 1923 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7B | 20.1B |
| IPO Year | 1961 | N/A |
| Metric | NMR | WST |
|---|---|---|
| Price | $7.82 | $279.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $346.78 |
| AVG Volume (30 Days) | ★ 887.2K | 661.6K |
| Earning Date | 10-28-2025 | 10-23-2025 |
| Dividend Yield | ★ 2.42% | 0.31% |
| EPS Growth | ★ 36.89 | 0.17 |
| EPS | 0.82 | ★ 6.75 |
| Revenue | ★ $13,470,548,516.00 | $3,017,900,000.00 |
| Revenue This Year | $2.08 | $7.01 |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | ★ $9.05 | $41.51 |
| Revenue Growth | ★ 11.80 | 4.92 |
| 52 Week Low | $4.86 | $187.43 |
| 52 Week High | $7.98 | $348.90 |
| Indicator | NMR | WST |
|---|---|---|
| Relative Strength Index (RSI) | 66.91 | 55.28 |
| Support Level | $7.18 | $269.08 |
| Resistance Level | $7.98 | $285.54 |
| Average True Range (ATR) | 0.12 | 7.15 |
| MACD | 0.07 | 1.29 |
| Stochastic Oscillator | 85.00 | 82.62 |
Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions world-wide, including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking, which is engaged in advisory, financing, and solutions businesses.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.